Bristol-Myers Squibb (Switzerland)

company CH

Publications

1,641

Citations

Researchers

Publications

View All

Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma

Noopur Raje , Jesús G. Berdeja , Yi Lin +20 more

We report the initial toxicity profile of a BCMA-directed cellular immunotherapy for patients with relapsed or refractory multiple myeloma. Antitumor activity was documented. (F...

2019 New England Journal of Medicine 1641 citations

Affiliated Researchers

Institution Info

Type: company
Country: CH
Publications: 1
Citations: 1,641

External Links

Identifiers

ROR: https://ror.org/02xqc6638

Publications

Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma

Affiliated Researchers

Julie Wang

Greg Russotti

Zhihong Yang

Institution Info

External Links

Identifiers